Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0BP3E
|
|||
| Former ID |
DNC005333
|
|||
| Drug Name |
(1,1-Difluoro-pentadecyl)-phosphonic acid
|
|||
| Synonyms |
CHEMBL188859; (1,1-Difluoro-pentadecyl)-phosphonic acid; SCHEMBL193245; YGXPAGSHLFJKFV-UHFFFAOYSA-N; BDBM50170861; ZINC36178965; (1,1-Difluoro-pentadecyl)Phosphonic Acid; (1,1-Difluoro-pentadecyl) Phosphonic Acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H31F2O3P
|
|||
| Canonical SMILES |
CCCCCCCCCCCCCCC(F)(F)P(=O)(O)O
|
|||
| InChI |
1S/C15H31F2O3P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15(16,17)21(18,19)20/h2-14H2,1H3,(H2,18,19,20)
|
|||
| InChIKey |
YGXPAGSHLFJKFV-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Lysophosphatidic acid receptor 1 (LPAR1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Rap1 signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| PI3K-Akt signaling pathway | ||||
| Gap junction | ||||
| Pathways in cancer | ||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| Pathway Interaction Database | LPA receptor mediated events | |||
| Reactome | G alpha (q) signalling events | |||
| G alpha (i) signalling events | ||||
| Lysosphingolipid and LPA receptors | ||||
| WikiPathways | Myometrial Relaxation and Contraction Pathways | |||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activ... J Med Chem. 2005 Jul 28;48(15):4919-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.